- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 143 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- March 2025
- 188 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- January 2022
- 64 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- September 2023
- 125 Pages
Global
From €3500EUR$3,949USD£3,056GBP
The Cardiovascular Implant market is a subset of the Cardiovascular Devices market, which includes a wide range of products used to diagnose, treat, and monitor cardiovascular diseases. Cardiovascular Implants are medical devices that are surgically implanted into the body to treat cardiovascular diseases. These devices include pacemakers, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). They are designed to regulate the heart rate, detect arrhythmias, and provide mechanical support to the heart.
Cardiovascular Implants are used to treat a variety of cardiovascular diseases, including arrhythmias, heart failure, and coronary artery disease. They are also used to improve the quality of life of patients with cardiovascular diseases.
Some of the major companies in the Cardiovascular Implant market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Sorin Group. These companies are involved in the development, manufacturing, and marketing of cardiovascular implants. Show Less Read more